Do analysts rate DYNT or RBOT?

Given Dynatronics' higher probable upside, research analysts clearly believe Dynatronics is more favorable than Vicarious Surgical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts rate BIOL or RBOT?

Given BIOLASE's higher possible upside, analysts clearly believe BIOLASE is more favorable than Vicarious Surgical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIOLASE 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is BIOL or RBOT more profitable?

Vicarious Surgical has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. Vicarious Surgical's return on equity of -184.13% beat BIOLASE's return on equity. Company Net Margins Return on Equity Return on Assets BIOLASE -41.65% -1,782.73% -55.31% Vicarious Surgical N/A -184.13% -112.50%

Do analysts rate VERO or RBOT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Venus Concept 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts rate RBOT or SDCCQ?

Given SmileDirectClub's higher probable upside, analysts plainly believe SmileDirectClub is more favorable than Vicarious Surgical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 SmileDirectClub 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is RBOT or SDCCQ more profitable?

SmileDirectClub's return on equity of 0.00% beat Vicarious Surgical's return on equity. Company Net Margins Return on Equity Return on Assets Vicarious Surgical N/A -184.13% -112.50% SmileDirectClub N/A N/A N/A

Do analysts recommend SSKN or RBOT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Vicarious Surgical (RBOT) Competitors

$0.05 0.00 (-7.76%)

As of 02:32 PM Eastern

Compare

RBOT vs. DYNT, BIOL, VERO, SDCCQ, and SSKN

Should you buy Vicarious Surgical stock or one of its competitors? Vicarious Surgical's main competitors and comparable companies include Dynatronics (DYNT), BIOLASE (BIOL), Venus Concept (VERO), SmileDirectClub (SDCCQ), and Strata Skin Sciences (SSKN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Vicarious Surgical compare to Dynatronics?

Dynatronics (NASDAQ:DYNT) and Vicarious Surgical (NYSE:RBOT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

In the previous week, Dynatronics had 1 more articles in the media than Vicarious Surgical. MarketBeat recorded 1 mentions for Dynatronics and 0 mentions for Vicarious Surgical. Dynatronics' average media sentiment score of 0.00 equaled Vicarious Surgical'saverage media sentiment score.

Company	Overall Sentiment
Dynatronics	Neutral
Vicarious Surgical	Neutral

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by insiders. Comparatively, 11.1% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Given Dynatronics' higher probable upside, research analysts clearly believe Dynatronics is more favorable than Vicarious Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Vicarious Surgical has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Vicarious Surgical	N/A	-184.13%	-112.50%

Dynatronics has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Vicarious Surgical has a beta of 1.86, suggesting that its share price is 86% more volatile than the broader market.

Dynatronics has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A

Summary

Dynatronics beats Vicarious Surgical on 7 of the 13 factors compared between the two stocks.

How does Vicarious Surgical compare to BIOLASE?

BIOLASE (NASDAQ:BIOL) and Vicarious Surgical (NYSE:RBOT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

Vicarious Surgical has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. Vicarious Surgical's return on equity of -184.13% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BIOLASE	-41.65%	-1,782.73%	-55.31%
Vicarious Surgical	N/A	-184.13%	-112.50%

BIOLASE has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, Vicarious Surgical has a beta of 1.86, meaning that its stock price is 86% more volatile than the broader market.

8.8% of BIOLASE shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 0.3% of BIOLASE shares are owned by company insiders. Comparatively, 11.1% of Vicarious Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, BIOLASE's average media sentiment score of 0.00 equaled Vicarious Surgical'saverage media sentiment score.

Company	Overall Sentiment
BIOLASE	Neutral
Vicarious Surgical	Neutral

Given BIOLASE's higher possible upside, analysts clearly believe BIOLASE is more favorable than Vicarious Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIOLASE	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

BIOLASE has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIOLASE	$48.83M	0.00	-$20.63M	-$14.94	N/A
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A

Summary

Vicarious Surgical beats BIOLASE on 7 of the 12 factors compared between the two stocks.

How does Vicarious Surgical compare to Venus Concept?

Venus Concept (NASDAQ:VERO) and Vicarious Surgical (NYSE:RBOT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

In the previous week, Venus Concept's average media sentiment score of 0.00 equaled Vicarious Surgical'saverage media sentiment score.

Company	Overall Sentiment
Venus Concept	Neutral
Vicarious Surgical	Neutral

87.4% of Venus Concept shares are held by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are held by institutional investors. 28.0% of Venus Concept shares are held by company insiders. Comparatively, 11.1% of Vicarious Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Venus Concept has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Venus Concept	$58.88M	0.01	-$47M	-$48.84	N/A
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A

Vicarious Surgical has a net margin of 0.00% compared to Venus Concept's net margin of -92.76%. Vicarious Surgical's return on equity of -184.13% beat Venus Concept's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Venus Concept	-92.76%	-1,904.25%	-85.22%
Vicarious Surgical	N/A	-184.13%	-112.50%

Venus Concept has a beta of -0.06, meaning that its stock price is 106% less volatile than the broader market. Comparatively, Vicarious Surgical has a beta of 1.86, meaning that its stock price is 86% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Venus Concept	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Vicarious Surgical beats Venus Concept on 6 of the 11 factors compared between the two stocks.

How does Vicarious Surgical compare to SmileDirectClub?

Vicarious Surgical (NYSE:RBOT) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

SmileDirectClub's return on equity of 0.00% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
SmileDirectClub	N/A	N/A	N/A

Given SmileDirectClub's higher probable upside, analysts plainly believe SmileDirectClub is more favorable than Vicarious Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
SmileDirectClub	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Vicarious Surgical's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company	Overall Sentiment
Vicarious Surgical	Neutral
SmileDirectClub	Neutral

47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 11.1% of Vicarious Surgical shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Vicarious Surgical has a beta of 1.86, meaning that its share price is 86% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market.

Vicarious Surgical has higher earnings, but lower revenue than SmileDirectClub. Vicarious Surgical is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
SmileDirectClub	$470.74M	0.00	-$86.40M	-$0.13	N/A

Summary

SmileDirectClub beats Vicarious Surgical on 7 of the 11 factors compared between the two stocks.

How does Vicarious Surgical compare to Strata Skin Sciences?

Strata Skin Sciences (NASDAQ:SSKN) and Vicarious Surgical (NYSE:RBOT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

Vicarious Surgical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Vicarious Surgical's return on equity of -184.13% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Skin Sciences	-35.64%	-476.73%	-33.49%
Vicarious Surgical	N/A	-184.13%	-112.50%

32.4% of Strata Skin Sciences shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 40.9% of Strata Skin Sciences shares are owned by insiders. Comparatively, 11.1% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Strata Skin Sciences has a beta of 0.03, suggesting that its share price is 97% less volatile than the broader market. Comparatively, Vicarious Surgical has a beta of 1.86, suggesting that its share price is 86% more volatile than the broader market.

Strata Skin Sciences has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Skin Sciences	$30.98M	0.00	-$10.09M	-$1.41	N/A
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A

In the previous week, Strata Skin Sciences' average media sentiment score of 0.00 equaled Vicarious Surgical'saverage media sentiment score.

Company	Overall Sentiment
Strata Skin Sciences	Neutral
Vicarious Surgical	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Vicarious Surgical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Strata Skin Sciences beats Vicarious Surgical on 6 of the 11 factors compared between the two stocks.

Get Vicarious Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RBOT vs. The Competition

Export

Metric	Vicarious Surgical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$322K	$5.51B	$7.20B	$22.93B
Dividend Yield	N/A	1.79%	2.53%	3.62%
P/E Ratio	0.00	25.23	274.69	28.18
Price / Sales	N/A	43.91	644.10	21.12
Price / Cash	N/A	32.79	76.31	39.12
Price / Book	0.01	5.78	10.44	4.68
Net Income	-$63.22M	$151.55M	$3.49B	$1.07B
7 Day Performance	N/A	1.53%	0.66%	-0.30%
1 Month Performance	N/A	-3.65%	-3.30%	-4.27%
1 Year Performance	N/A	5.93%	16.20%	7.55%

Vicarious Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RBOT Vicarious Surgical	N/A	$0.05 -7.8%	N/A	-99.2%	$322K	N/A	N/A	210	Gap Up
DYNT Dynatronics	N/A	N/A	N/A	N/A	$653K	$33.60M	N/A	200
BIOL BIOLASE	N/A	N/A	N/A	N/A	$581K	$48.83M	N/A	160
VERO Venus Concept	0.1266 of 5 stars	$0.31 flat	N/A	N/A	$442K	$58.88M	N/A	410
SDCCQ SmileDirectClub	N/A	$0.00 flat	N/A	N/A	$40K	$470.74M	N/A	2,700	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:RBOT) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vicarious Surgical (RBOT) Competitors

RBOT vs. DYNT, BIOL, VERO, SDCCQ, and SSKN

How does Vicarious Surgical compare to Dynatronics?

Summary

How does Vicarious Surgical compare to BIOLASE?

Summary

How does Vicarious Surgical compare to Venus Concept?

Summary

How does Vicarious Surgical compare to SmileDirectClub?

Summary

How does Vicarious Surgical compare to Strata Skin Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RBOT vs. The Competition

Vicarious Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vicarious Surgical (RBOT) Competitors

RBOT vs. DYNT, BIOL, VERO, SDCCQ, and SSKN

How does Vicarious Surgical compare to Dynatronics?

Does the media refer more to DYNT or RBOT?

Do institutionals and insiders hold more shares of DYNT or RBOT?

Do analysts rate DYNT or RBOT?

Is DYNT or RBOT more profitable?

Which has more volatility and risk, DYNT or RBOT?

Which has stronger valuation & earnings, DYNT or RBOT?

Summary

How does Vicarious Surgical compare to BIOLASE?

Is BIOL or RBOT more profitable?

Which has more risk and volatility, BIOL or RBOT?

Do insiders & institutionals hold more shares of BIOL or RBOT?

Does the media prefer BIOL or RBOT?

Do analysts rate BIOL or RBOT?

Which has higher valuation and earnings, BIOL or RBOT?

Summary

How does Vicarious Surgical compare to Venus Concept?

Does the media prefer VERO or RBOT?

Do institutionals & insiders have more ownership in VERO or RBOT?

Which has stronger valuation and earnings, VERO or RBOT?

Is VERO or RBOT more profitable?

Which has more risk & volatility, VERO or RBOT?

Do analysts rate VERO or RBOT?

Summary

How does Vicarious Surgical compare to SmileDirectClub?

Is RBOT or SDCCQ more profitable?

Do analysts rate RBOT or SDCCQ?

Does the media prefer RBOT or SDCCQ?

Do insiders & institutionals have more ownership in RBOT or SDCCQ?

Which has more volatility & risk, RBOT or SDCCQ?

Which has better earnings & valuation, RBOT or SDCCQ?

Summary

How does Vicarious Surgical compare to Strata Skin Sciences?

Is SSKN or RBOT more profitable?

Do insiders and institutionals believe in SSKN or RBOT?

Which has more volatility and risk, SSKN or RBOT?

Which has stronger earnings & valuation, SSKN or RBOT?

Does the media refer more to SSKN or RBOT?

Do analysts recommend SSKN or RBOT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RBOT vs. The Competition

Vicarious Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools